Phibro Animal Health | PAHC - Interest Expense On Debt


Phibro Animal Health reported $11.91M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Align Technology USD 6.93M 9.11M Mar/2026
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Aurora Cannabis CAD 230K 1.88M Mar/2026
Bristol-Myers Squibb USD 407M 4M Jun/2026
Canopy Growth CAD 12.31M 4.97M Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Henry Schein USD 39M 0 Mar/2026
Idexx Laboratories USD 7.74M 2.34M Mar/2026
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Merck USD 479M 67M Mar/2026
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Pacira USD 3.7M 193K Mar/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Zoetis USD 62M 5M Mar/2026